Our Partners

OCT has combined innovation with technical expertise to develop an efficient drug development strategy which includes operating a partnership model with an extensive network of external academic and commercial partners. This approach lowers both developmental risk and costs, and shortens the timeframe to commercialisation without compromising on the crucial safety and efficacy testing required for regulatory approval.

Programme 1

Optical illusion showing a duck and a rabbit, depending on the viewer's perspective.
Albert Einstein drawing, geometric style, black and white
abstract drawing of a cat with elongated legs and small head
Silhouette of a cat sitting gracefully with tail curled.
man with goat head illustration, surreal art
Benzene chemical structure diagram

Programme 2

silhouette of a person jumping in the air with arms raised
Black and white sketch of a large figure resembling Totoro from Studio Ghibli films, standing under a small umbrella in the rain.
Smiley face hand gesture vector illustration
Eiffel Tower line drawing with a heart and cursive 'Paris' text
Black silhouette of a person with umbrella in raining cloud
Starbucks coffee cup with lid
Geometric abstract design with intersecting lines and shapes

Programmes 3 & 4

Silhouette of a man jumping with outstretched arms and legs against a white background.
Record player with vinyl disc and stylus
Silhouette of a person sitting cross-legged with hands resting on knees, meditating.

The deal with Canopy Growth Corporation, for example, has quadrupled OCT’s existing proprietary cannabinoid derivative and patent family library which will enhance programmes 3 and 4, while potentially supporting and expanding additional drug development programmes.

Artistic image blending a woman lying down with a microscope, overlaid with digital network elements.